Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for persistent hyperplastic primary vitreous, autosomal dominant.
2 publications have been identified in PubMed for persistent hyperplastic primary vitreous, autosomal dominant. Research spans Case Report / Case Series (100%).
Jellal S (2025). [PMID: 39539385](https://pubmed.ncbi.nlm.nih.gov/39539385/). *Radiol Case Rep*. [Case Report / Case Series]
Silva NÁ (2024). [PMID: 39187757](https://pubmed.ncbi.nlm.nih.gov/39187757/). *BMC Ophthalmol*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-curated news mentioning persistent hyperplastic primary vitreous, autosomal dominant
Updated Jun 7, 2026
A recent case report highlights the association between CHARGE syndrome and persistent hyperplastic primary vitreous, contributing to the understanding of ocular manifestations in this rare condition. This discovery may inform future research and clinical approaches to managing patients with CHARGE syndrome.